|
Gene: ZKSCAN1 |
Gene summary for ZKSCAN1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | ZKSCAN1 | Gene ID | 7586 |
Gene name | zinc finger with KRAB and SCAN domains 1 | |
Gene Alias | KOX18 | |
Cytomap | 7q22.1 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | B3KNP9 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7586 | ZKSCAN1 | S016 | Human | Liver | HCC | 4.05e-07 | 8.85e-01 | 0.2243 |
7586 | ZKSCAN1 | S027 | Human | Liver | HCC | 7.29e-24 | 4.15e+00 | 0.2446 |
7586 | ZKSCAN1 | S028 | Human | Liver | HCC | 5.14e-49 | 4.81e+00 | 0.2503 |
7586 | ZKSCAN1 | S029 | Human | Liver | HCC | 6.34e-38 | 4.51e+00 | 0.2581 |
7586 | ZKSCAN1 | RNA-P17T-P17T-2 | Human | Lung | IAC | 2.01e-03 | 4.10e-01 | 0.3371 |
7586 | ZKSCAN1 | RNA-P17T-P17T-4 | Human | Lung | IAC | 1.07e-07 | 7.47e-01 | 0.343 |
7586 | ZKSCAN1 | RNA-P17T-P17T-6 | Human | Lung | IAC | 1.34e-06 | 6.57e-01 | 0.3385 |
7586 | ZKSCAN1 | RNA-P17T-P17T-8 | Human | Lung | IAC | 7.17e-03 | 3.93e-01 | 0.3329 |
7586 | ZKSCAN1 | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 4.28e-02 | 2.05e-01 | -0.0166 |
7586 | ZKSCAN1 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 6.04e-06 | 2.33e-01 | -0.0132 |
7586 | ZKSCAN1 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 1.05e-06 | 2.42e-01 | -0.013 |
7586 | ZKSCAN1 | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 1.14e-04 | 2.82e-01 | -0.0121 |
7586 | ZKSCAN1 | C04 | Human | Oral cavity | OSCC | 2.10e-09 | 4.26e-01 | 0.2633 |
7586 | ZKSCAN1 | C21 | Human | Oral cavity | OSCC | 3.26e-22 | 8.64e-01 | 0.2678 |
7586 | ZKSCAN1 | C30 | Human | Oral cavity | OSCC | 3.47e-15 | 6.42e-01 | 0.3055 |
7586 | ZKSCAN1 | C38 | Human | Oral cavity | OSCC | 2.17e-13 | 1.69e+00 | 0.172 |
7586 | ZKSCAN1 | C43 | Human | Oral cavity | OSCC | 5.89e-05 | 1.96e-01 | 0.1704 |
7586 | ZKSCAN1 | C46 | Human | Oral cavity | OSCC | 2.02e-25 | 7.24e-01 | 0.1673 |
7586 | ZKSCAN1 | C51 | Human | Oral cavity | OSCC | 1.22e-11 | 6.64e-01 | 0.2674 |
7586 | ZKSCAN1 | C57 | Human | Oral cavity | OSCC | 3.20e-12 | 4.23e-01 | 0.1679 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZKSCAN1 | SNV | Missense_Mutation | c.229C>G | p.Leu77Val | p.L77V | P17029 | protein_coding | deleterious(0) | possibly_damaging(0.744) | TCGA-A2-A04T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | |
ZKSCAN1 | SNV | Missense_Mutation | rs772572650 | c.1523G>A | p.Arg508Gln | p.R508Q | P17029 | protein_coding | tolerated(1) | benign(0.117) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZKSCAN1 | SNV | Missense_Mutation | c.1589N>G | p.Ser530Cys | p.S530C | P17029 | protein_coding | deleterious(0) | possibly_damaging(0.785) | TCGA-BH-A0W3-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ZKSCAN1 | SNV | Missense_Mutation | novel | c.1307N>G | p.Asn436Ser | p.N436S | P17029 | protein_coding | deleterious(0.05) | benign(0.024) | TCGA-E9-A1ND-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | aromasin | SD |
ZKSCAN1 | insertion | Nonsense_Mutation | novel | c.551_552insCTCCAAGCAAACACCCTGAGGGTGGAGTCGGCCTGTTTGAGGTT | p.Arg185SerfsTer6 | p.R185Sfs*6 | P17029 | protein_coding | TCGA-BH-A0HK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | ||
ZKSCAN1 | insertion | Frame_Shift_Ins | novel | c.19_20insG | p.Glu8GlyfsTer26 | p.E8Gfs*26 | P17029 | protein_coding | TCGA-BH-A1EN-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
ZKSCAN1 | SNV | Missense_Mutation | novel | c.1358N>A | p.Arg453His | p.R453H | P17029 | protein_coding | deleterious(0) | probably_damaging(0.982) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ZKSCAN1 | SNV | Missense_Mutation | novel | c.523G>A | p.Ala175Thr | p.A175T | P17029 | protein_coding | tolerated(0.62) | benign(0) | TCGA-AA-3947-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZKSCAN1 | SNV | Missense_Mutation | c.883N>A | p.Gly295Arg | p.G295R | P17029 | protein_coding | deleterious(0.04) | benign(0.044) | TCGA-AG-3878-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
ZKSCAN1 | deletion | Frame_Shift_Del | c.1012delN | p.Thr340ProfsTer21 | p.T340Pfs*21 | P17029 | protein_coding | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |